INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
14/03/2026
Voltar para busca
Dado oficial do USPTO
GUTPLUS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
36
Atualização mais recente
15/03/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 31
Data de depósito
31/03/2016
Data de registro
21/11/2017
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
14/07/2025
Última transação
15/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
98
Localização do titular
Essen, DE
Examinador
SINGH, TEJBIR
Localização atual
Historical data usage
Titulares e representantes
Titulares
Evonik Operations GmbH
Evonik Degussa GmbH
Representantes
Scott D. Woldow Smith, Gambrell & Russell, LLP
Classificação técnica
Classes Nice
Classe 5Classe 31
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical and veterinary preparations for the prevention and for the treatment of nutrition deficiencies and disorders; Pharmaceutical and veterinary preparations for the prevention and treatment of ocular disorders or diseasesbacteria-based diseases or disordersautoimmune diseases or disorderskidney diseases or disordersdiabetes; Pharmaceutical and veterinary preparations for the prevention and treatment of necrotic enteritis; medical and veterinary preparations for the prevention and for the treatment of nutrition deficiencies and disorders; medical and veterinary preparations for the prevention and for the treatment of ocular disorders or diseasesbacteria-based diseases or disordersautoimmune diseases or disorderskidney diseases or disordersdiabetes; medical and veterinary preparationsfodder acidifiers for medical purposes and fodder additives for medical purposes in form of amino acidspeptides and proteins and mixtures thereof; medical and veterinary preparations for the prevention and for the treatment of necrotic enteritis; chemical preparations for medicalpharmaceutical and veterinary purposes for the prevention and for the treatment of nutrition deficiencies and disorders; chemical preparations for medicalpharmaceutical and veterinary purposes for the prevention and for the treatment of ocular disorders or diseasesbacteria-based diseases or disordersautoimmune diseases or disorderskidney diseases or disordersdiabetes; chemical preparations for medicalpharmaceutical and veterinary purposes for the prevention and for the treatment of necrotic enteritis; amino acids for medical and veterinary purposes; estersoils and greases for medical and veterinary purposes; saltsin particular potassium and sodium salts for medical purposes; steroids; ferments for pharmaceutical purposes; yeast or starch for dietetic or pharmaceutical purposes; enzymes and enzyme preparations for medical and veterinary purposes; biological preparations for the treatment of nutrition conditions; bacteriological preparations for medical and veterinary purposes; cultures of microorganisms for medical and veterinary use; nutritive substances for microorganisms for medical purposes; bouillons for bacteriological cultures; dietetic foodsnamely pasta and crackers adapted for medical or veterinary use; dietetic preparationsnamely sugar substitutes for medical use and dietary supplements; albuminous preparations for medical purposes; candymedicated; medicinal drinks; dietetic beverages adapted for medical purposes; medical preparations for slimming purposes; food for babies; nutritional supplements for humans; dietary supplements for animals; Medical preparationsprobiotic supplements; Dietary supplements for animalsprobiotic animal feed; nutritional supplements for humansprobiotic compositions; sugarin particular candy and glucose for medical purposes; glucose for medical purposes; albuminous foodstuffs for medical purposes; protein dietary supplements; dietary fibre; mineral food supplements; preparations of trace elements for human and animal use; vitamin preparations; animal feed supplementsnot for medical purposes; animal feed supplementsnon-medicated additives for animal feed for use as nutritional supplements; micro-nutrient animal feed for fish and aquacultures; feed supplementsnamely synthetic peptides for the treatment of nutrition deficiencies; protein supplements for animals; amino acids for nutritional purposes for use in animal feedfish food and aquaculture
Classe 31
Agriculturalhorticultural and forestry products as well as products for aquacultureaquaculture feed; live animals; foodstuffs and fodder for animals; bedding and litter for animalscellulose for use as animal bedding; animal feed preparationsanimal feed; yeast for animal consumption
Publicações
Histórico de despachos e eventos da marca no USPTO.
36 publicações encontradas
NC71
NOTICE OF CANCELLATION SEC. 71 E-MAILED
14/07/2025
C71T
CANCELLED SECTION 71
14/07/2025
PR71
POST REGISTRATION ACTION MAILED - SEC.71
17/12/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
16/12/2024
ES71
TEAS SECTION 71 RECEIVED
17/05/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
21/11/2022
CHLD
CHANGE OF OWNER RECEIVED FROM IB
14/05/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
13/04/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
22/02/2018
FIMP
FINAL DISPOSITION PROCESSED
22/02/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
21/02/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
21/11/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/09/2017
PUBO
PUBLISHED FOR OPPOSITION
05/09/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
16/08/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/08/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/07/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/07/2017
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/07/2017
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/06/2017
GNFR
FINAL REFUSAL E-MAILED
06/06/2017
CNFR
FINAL REFUSAL WRITTEN
06/06/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/06/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/06/2017
ALIE
ASSIGNED TO LIE
24/05/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/05/2017
RFNT
REFUSAL PROCESSED BY IB
18/11/2016
MAFR
APPLICATION FILING RECEIPT MAILED
05/11/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/11/2016
RFRR
REFUSAL PROCESSED BY MPU
03/11/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/11/2016
CNRT
NON-FINAL ACTION WRITTEN
01/11/2016
DOCK
ASSIGNED TO EXAMINER
01/11/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/11/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
27/10/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace GUTPLUS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.